5-(p-AMINOFENIL)-4-AMINO-1,2,4-TRIAZOL-3(2H)-TIONNING O‘TKIR ZAHARLILIGI VA TUTQANOQQA QARSHI FAOLLIGI

Article Sidebar

PDF (Uzbek (latin))
Выпуск: Том 5 № 2 Part 2 : Евразийский журнал медицинских и естественных наук
Раздел: Статьи
Опубликован:
Лицензия Creative Commons

Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.

Main Article Content

O‘zRFA O‘simlik moddalari kimyosi instituti, O‘zbekiston
info@in-academy.uz
O‘zRFA O‘simlik moddalari kimyosi instituti, O‘zbekiston Toshkent davlat stomatologiya instituti, O‘zbekiston
info@in-academy.uz
O‘zRFA O‘simlik moddalari kimyosi instituti, O‘zbekiston
info@in-academy.uz
O‘zRFA O‘simlik moddalari kimyosi instituti, O‘zbekiston
info@in-academy.uz
O‘zRFA O‘simlik moddalari kimyosi instituti, O‘zbekiston
info@in-academy.uz
O‘zRFA O‘simlik moddalari kimyosi instituti, O‘zbekiston
info@in-academy.uz
O‘zRFA O‘simlik moddalari kimyosi instituti, O‘zbekiston
info@in-academy.uz

Аннотация:

Ushbu maqolada 5-(p-aminofenil)-4-amino-1,2,4-triazol-3(2H)-tion kam zaharli sinfga mansub ekanligi, 0.1; 0.5; 1.0; 5.0 va 10.0 mg/kg dozalarda psixofarmakologik faolliklari va tutqanoqqa qarshi solishtirma preparatlar karbamazepin va konvuleksdan qolishmasligi eksperimental tajribalar asosida tasdiqlangan.

Article Details

Как цитировать:

Rahimboyev, S., Sanoev , Z. ., Hamroyev , T., Abdinazarov , I. ., Rashidov , S. ., Ismoilova , D. ., & Elmuradov , B. (2025). 5-(p-AMINOFENIL)-4-AMINO-1,2,4-TRIAZOL-3(2H)-TIONNING O‘TKIR ZAHARLILIGI VA TUTQANOQQA QARSHI FAOLLIGI. Евразийский журнал медицинских и естественных наук, 5(2 Part 2), 110–118. извлечено от https://in-academy.uz/index.php/EJMNS/article/view/46508

Библиографические ссылки:

Strine TW, Kobau R, Chapman DP, Thurman DJ, Price P, Balluz LS. Psychological distress comorbidities and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview Survey. Epilepsia. 2005 Jul;46(7):1133-9. doi:10.1111/j.1528-1167.2005.01605.x, PMID 16026567.

Ashhar MU, Ahmad MZ, Jain V, Agarwal NB, Ahmad FJ, Jain GK. Intranasal pitavastatin attenuates seizures in different experimental models of epilepsy in mice. Epilepsy Behav. 2017 Oct 1;75:56-9. doi: 10.1016/j.yebeh.2017.07.004, PMID 28826009.

Soares DA Silva P, Pires N, Bonifacio MJ, Loureiro AI, Palma N, Wright LC. Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action. Pharmacol Res Perspect. 2015 Mar;3(2):e00124. Doi:10.1002/prp2.124, PMID 26038700

Hanada T. The discovery and development of perampanel for the treatment of epilepsy. Expert Opin Drug Discov. 2014 Apr 1;9(4):449-58. doi: 10.1517/17460441.2014.891580, PMID 24559052.

Large CH, Sokal DM, Nehlig A, Gunthorpe MJ, Sankar R, Crean CS. The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use. Epilepsia. 2012 Mar;53(3):425-36. doi: 10.1111/j.1528- 1167.2011.03364.x, PMID 22221318.

Kamboj VK, Verma PK, Dhanda A, Ranjan S. 1,2,4-triazole derivatives as a potential scaffold for anticonvulsant activity. Cent Nerv Syst Agents Med Chem. 2015 Apr 1;15(1):17-22. doi: 10.2174/1871524915666150209100533, PMID 25675400.

Ben Menachem E. Medical management of refractory epilepsy practical treatment with novel antiepileptic drugs. Epilepsia. 2014 Jan;55 Suppl 1:3-8. doi: 10.1111/epi.12494, PMID 24400690.

Luszczki JJ, Plech T, Wujec M. Effect of 4-(4-bromophenyl)-5-(3- chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock induced seizure model. Eur J Pharmacol. 2012 Sep 5;690(1-3):99-106. doi: 10.1016/j.ejphar.2012.06.023, PMID 22732650.

Loring DW, Meador KJ. Cognitive side effects of antiepileptic drugs in children. Neurology. 2004 Mar 23;62(6):872-7. doi: 10.1212/01.wnl.0000115653.82763.07, PMID 15037684.

Chen B, Choi H, Hirsch LJ, Katz A, Legge A, Buchsbaum R. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 2017 Nov 1;76:24-31. doi: 10.1016/j.yebeh.2017.08.039, PMID 28931473.

Deka D, Chakravarty PI, Purkayastha AY. Evaluation of the anticonvulsant effect of aqueous extract of Centella asiatica in albino mice. Int J Pharm Pharm Sci. 2017;9(2):312-4. doi: 10.22159/ijpps.2017v9i2.15483.

Karakucuk Iyidogan A, Basaran E, Tatar Yilmaz G, Oruc Emre EE. Development of new chiral 1,2,4-triazole-3-thiones and 1,3,4-thiadiazoles with promising in vivo anticonvulsant activity targeting GABAergic system and voltage-gated sodium channels (VGSCs). Bioorg Chem. 2024 Oct 1;151:107662. doi:10.1016/j.bioorg.2024.107662, PMID 39079390.

Rani S, Teotia S, Nain S. Recent advancements and biological activities of triazole derivatives: a short review. Pharm Chem J. 2024 Apr 15;57(12):1909-17. doi: 10.1007/s11094-024-03096- z.

Mula M. GABAergic drugs in the treatment of epilepsy: modern or outmoded? Future Med Chem. 2011 Feb;3(2):177-82. doi: 10.4155/fmc.10.296, PMID 21428812.

Froestl W. An historical perspective on GABAergic drugs. Future Med Chem. 2011 Feb;3(2):163-75. doi: 10.4155/fmc.10.285, PMID 21428811.

Plech T, Luszczki JJ, Wujec M, Flieger J, Pizon M. Synthesis characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1,2,4-triazoles. Eur J Med Chem. 2013 Feb 1;60:208-15. doi: 10.1016/j.ejmech.2012.11.026, PMID 23291122.

Sanoev Z.I., Ismailova D.S., Rakhimboev S.D., Tolibovich T.T., Elmuradov B.J., Abdinazarov I.T., Rashidov S.Z. (2023). Synthesis And Research Anticonvulsant Activity Of Annulated Triazolo-thiadiazine Derivative In Laboratory Animals. Biomedical & Pharmacology Journal. Vol. 16(4), p. 2457-2467.

Matin MM, Matin P, Rahman MR, Ben Hadda T, Almalki FA, Mahmud S. Triazoles and their derivatives: chemistry synthesis and therapeutic applications. Front Mol Biosci. 2022 Apr 25;9:864286. doi: 10.3389/fmolb.2022.864286, PMID 35547394, PMCID PMC9081720.

Zhang Y, Wang M, Ahmed M, HE L, JI M, QI Z. Synthesis fungicidal activity and SAR of 3,4-dichloroisothiazole based cycloalkyl sulfonamides. Bioorg Med Chem Lett. 2019 Jun 1;29(11):1345-9. doi: 10.1016/j.bmcl.2019.03.047, PMID 30956010.

Zhang Y, Wang M, Ahmed M, He L, JI M, QI Z. Synthesis fungicidal activity and SAR of 3,4-dichloroisothiazolebased cycloalkylsulfonamides. Bioorg Med Chem Lett. 2019;29(11):1345-49. doi: 10.1016/j.bmcl.2019.03.047, PMID 30956010.

Султонов, С. А. У., & Саноев, З. И. (2024). Оценка нейротропной активности синтетических гетероциклических соединений (обзор литературы). Re-health journal, (4 (24)), 33-38.

Sanoev, Z. I., & Mirzaev, Y. R. (2020). Pharmacological activity of the possessing new atypical neuroleptics 1-phenyltetrahydroisoquinoline structure. The American Journal of Medical Sciences and Pharmaceutical Research, 18-26.

Sanoev, Z. I., & Mirzaev, Y. R. (2021). Research of a New Atypical Neuroleptic 1-(3, 4-Methylenedioxyphenyl)-6, 7-Methylenedioxy-1, 2, 3, 4-Tetrahydroisoquinoline on the Central Nervous System. Annals of the Romanian Society for Cell Biology, 25(2), 2363-2369.

Turan Zitouni G, Sivaci M, Kilic FS, Erol K. Synthesis of some triazolyl-antipyrine derivatives and investigation of analgesic activity. Eur J Med Chem. 2001 Aug 1;36(7-8):685-9. doi:10.1016/s0223-5234(01)01252-1, PMID 11600237.

Bekircan O, Kuxuk M, Kahveci B, Kolayli S. Convenient synthesis of fused heterocyclic 1,3,5-triazines from some N-acyl imidates and heterocyclic amines as anticancer and antioxidant agents. Arch Pharm Int. 2005 Aug;338(8):365-72. doi: 10.1002/ardp.200400964, PMID 16041836.

Wade PC, Vogt BR, Kissick TP, Simpkins LM, Palmer DM, Millonig RC. 1-Acyltriazoles as antiinflammatory agents. J Med Chem. 1982 Mar;25(3):331-3. doi: 10.1021/jm00345a021, PMID 6461764.

Mahdavi M, Akbarzadeh T, Sheibani V, Abbasi M, Firoozpour L, Tabatabai SA. Synthesis of two novel 3-amino-5-[4-chloro-2- phenoxyphenyl]-4H-1,2,4-triazoles with anticonvulsant activity. Iran J Pharm Res. 2010;9(3):265-9. PMID 24363736.

Modzelewska Banachiewicz B, Kalabun J. Synthesis and biological action of 5-oxo-1,2,4-triazine derivatives. Pharmazie. 1999 Jul 1;54(7):503-5. PMID 10445245.

Gupta D, Jain DK. Synthesis antifungal and antibacterial activity of novel 1,2,4-triazole derivatives. J Adv Pharm Technol Res. 2015 Jul 1;6(3):141-6. doi: 10.4103/2231-4040.161515, PMID 26317080.

Gao F, Wang T, Xiao J, Huang G. Antibacterial activity study of 1,2,4-triazole derivatives. Eur J Med Chem. 2019 Jul 1;173:274- 81. doi: 10.1016/j.ejmech.2019.04.043, PMID 31009913.

Gulerman N, Rollas S, Kiraz M, Ekinci AC, Vidin A. Evaluation of antimycobacterial and anticonvulsant activities of new 1-(4-fluorobenzoyl)-4-substituted thiosemicarbazide and 5-(4-fluorophenyl)-4-substituted-2,4-dihydro-3H-1,2,4-triazole-3-thione derivatives. Farmaco. 1997 Nov 1;52(11):691-5. PMID9550096.

Ikizler AA, Johansson CB, Bekircan O, Celik C. Drug synthesis. Acta Poloniae Pharnaceutica–Drug Research. 1999;56(4):283-8.

Shalini M, Yogeeswari P, Sriram D, Stables JP. Cyclization of the semicarbazone template of aryl semicarbazones: synthesis and anticonvulsant activity of 4,5-diphenyl-2H-1,2,4-triazol-3(4H) one. Biomed Pharmacother. 2009 Mar 1;63(3):187-93. doi:10.1016/j.biopha.2006.04.002, PMID 19422088.

Siddiqui N, Ahsan W. Triazole incorporated thiazoles as a new class of anticonvulsants: design, synthesis and in vivo screening. Eur J Med Chem. 2010 Apr 1;45(4):1536-43. doi: 10.1016/j.ejmech.2009.12.062, PMID 20116140.

Almasirad A, Tabatabai SA, Faizi M, Kebriaeezadeh A, Mehrabi N, Dalvandi A. Synthesis and anticonvulsant activity of new 2-substituted-5- [2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles. Bioorg Med Chem Lett. 2004 Dec 20;14(24):6057-9. doi: 10.1016/j.bmcl.2004.09.072, PMID15546729.